STEMI - ST Elevation Myocardial Infarction: Clinical Trials

81 trials for STEMI - ST Elevation Myocardial Infarction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

26 completed, 21 unknown, 11 recruiting, 10 not yet recruiting. 22 Not applicable, 15 Phase 4, 5 Phase 3, 4 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable22Completed 6, Unknown 6, Terminated 4, Not yet recruiting 3, Withdrawn 2, Recruiting 1
Phase 415Completed 5, Recruiting 3, Unknown 3, Not yet recruiting 2, Active not recruiting 1, Terminated 1
Phase 35Recruiting 3, Not yet recruiting 1, Unknown 1
Phase 24Completed 2, Not yet recruiting 1, Recruiting 1
Phase 12Completed 1, Not yet recruiting 1

Follow STEMI - ST Elevation Myocardial Infarction: new trials by email Literature Review of STEMI - ST Elevation Myocardial Infarction trials Research Report on STEMI - ST Elevation Myocardial Infarction

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hong Kong Cardiogenic Shock Initiative
Cardiogenic Shock Acute, STEMI - ST Elevation Myocardial Infarction
Not yet recruitingPrince of Wales Hospital, Shatin, Hong Kong3202026-12-012026-09-16
Noninvasive Artificial Venous Stasis for Reperfusion in STEMI
STEMI - ST Elevation Myocardial Infarction
RecruitingFirat University5002026-08-152026-08-18
Comparative Evaluation of Sustained meChanical AsPiration Thrombectomy and no Thrombus Modification for Pre-stent Thrombus bUrden Reduction in Patients With Acute Myocardial Infarction Study: the CAPTURE AMI Study
Sustained thrombectomy, Percutaneous Coronary Intervention - STEMI - ST Elevation Myocardial Infarction
Phase 2 / Phase 3RecruitingOxford University Hospitals NHS Trust602026-07-082026-07-10
Effect of Guanxinning Tablet on Coronary Microcirculation After Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction
Guanxinning Tablet(GXNT), Placebo - STEMI (ST Elevation MI), STEMI - ST Elevation Myocardial Infarction
Phase 2Not yet recruitingBeijing Anzhen Hospital702026-06-012026-06-02
Use of the Methoxyflurane as Pain-killer in the Prehospital Management of Acute Myocardial Infarction
Methoxyflurane, Morphine - STEMI - ST Elevation Myocardial Infarction
Phase 3Not yet recruitingAssistance Publique - Hôpitaux de Paris7002026-06-012026-03-03
Safety and Feasibility of Transcatheter Injectable Hydrogel in Acute STEMI Reperfusion Injury (REFINE Study)
Injectable protein alginate-based hydrogel, No additional intervention - STEMI - ST Elevation Myocardial Infarction
Not applicableNot yet recruitingMyomed Technology (Shaoxing) Co., Ltd.202026-05-302026-05-22
Reperfusion Approach in Predicted In-hospital Delay for Primary PCI in STEMI
Single, weight-adjusted i.v. bolus of tenecteplase, catheterisation - STEMI - ST Elevation Myocardial Infarction
Phase 4Not yet recruitingNational Medical Research Center for Cardiology, Ministry of Health of Russian Federation2402026-05-202026-06-11
The CORE - μFR Clinical Trial
Angiography-guided PCI, μFR based-PCI - Acute Coronary Syndromes (ACS), NSTEMI - Non-ST-Segment Elevation Myocardial Infarction
Not applicableNot yet recruitingUniversity of Roma La Sapienza3502026-05-182026-05-22
Prehospital Pulse-dose Glucocorticoid in Patients With ST-segment Elevation Myocardial Infarction 2 - The PULSE-MI 2 Trial
Methylprednisolone 250 mg, NaCl (0,9%) - STEMI - ST Elevation Myocardial Infarction
Phase 3RecruitingThomas Engstrom52042026-04-202026-04-23
Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia
Aspirin 100 mg, Clopidogrel 75 mg, Rivaroxaban 15 mg - Coronary Artery Ectasia, Acute Coronary Syndromes (ACS)
Phase 4RecruitingInstituto Nacional de Cardiologia Ignacio Chavez3262026-02-112026-04-09
Safety and Efficacy of FAP iCDC in Acute Myocardial Infarction With Cardiogenic Shock
FAP allogeneic immunosuppressive CAR-DC - Cardiogenic Shock, Cardiogenic Shock Post Myocardial Infarction
Phase 1Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine182026-01-202026-02-02
Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period
Recaticimab - STEMI - ST Elevation Myocardial Infarction, NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)
Phase 4Not yet recruitingSecond Affiliated Hospital of Nanchang University24422026-01-012025-12-18
Epicardial Cardiac Fat-CT (EPIC-CT)
Dapagliflozin 10 MG Oral Tablet, Semaglutide (Rybelsus®) - STEMI - ST Elevation Myocardial Infarction, Epicardial Fat
Phase 3RecruitingInstituto Mexicano del Seguro Social1362025-12-302026-01-02
Early Thrombolysis Guided by AI-Assisted App in Patients With STEMI
A novel artificial intelligence assisted mobile application - STEMI - ST Elevation Myocardial Infarction
Not applicableRecruitingShenyang Northern Hospital33562025-09-082025-09-18
Microvascular Obstruction Diagnosis Using the CoFI™ System Assessment - II
CorFlow Controlled Flow Infusion System - CoFI™ - Microvascular Obstruction (MVO), STEMI - ST Elevation Myocardial Infarction
Not applicableNot yet recruitingCorFlow Therapeutics AG2002025-09-012025-07-10
Emergency Medical Services (EMS) Telehealth to Speed STEMI Reperfusion
Telehealth - STEMI - ST Elevation Myocardial Infarction
CompletedWake Forest University Health Sciences112025-06-182026-04-02
Correlation Between Triglyceride Glucose Index and Residual SYNTAX Score in STEMI Patients Undergoing PPCI
Echocardiography - STEMI - ST Elevation Myocardial Infarction
Not yet recruitingAssiut University1852024-12-012024-10-15
SuperSaturated Oxygen Comprehensive Observational Registry
KCCQ, Eq5D, cMRI (Subset of patients) - STEMI - ST Elevation Myocardial Infarction, AMI
RecruitingTherOx10002024-08-132026-08-20
Efficacy of Using 50 ml Syringe Manual Thrombectomy Catheter in Primary PCI With Heavy Thrombus Burden
30 mL syringe manual thrombectomy catheter, 50 mL syringe manual thrombectomy catheter - STEMI - ST Elevation Myocardial Infarction, Thrombosis Cardiac
Phase 3UnknownHelwan University882024-04-012024-03-26
Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus
NOAC+DAPT, DAPT - STEMI - ST Elevation Myocardial Infarction
Phase 4RecruitingZunyi Medical College3742024-04-012024-03-19

Showing 20 of 81. Sign in to see all of them.

Narrower conditions

ST Elevation Myocardial Infarction (81)  ·  Non-ST Elevated Myocardial Infarction (13)  ·  Acute Coronary Syndrome (10)  ·  Myocardial Infarction (10)  ·  Coronary Artery Disease (8)  ·  Angina, Unstable (4)  ·  Shock, Cardiogenic (4)  ·  Thrombosis (3)  ·  Anterior Wall Myocardial Infarction (2)  ·  Coronary Disease (2)  ·  Hemorrhage (2)  ·  Acute Kidney Injury (1)  ·  Angina Pectoris (1)  ·  Angina, Stable (1)  ·  Aortic Dissection (1)

Broader conditions

Cardiovascular Diseases (81)  ·  Infarction (81)  ·  Ischemia (81)  ·  Myocardial Ischemia (81)  ·  Necrosis (81)  ·  Pathologic Processes (81)  ·  Pathological Conditions, Signs and Symptoms (81)  ·  Heart Diseases (80)  ·  Vascular Diseases (80)  ·  Myocardial Infarction (71)  ·  Coronary Disease (9)  ·  Arterial Occlusive Diseases (8)  ·  Arteriosclerosis (8)  ·  Neurologic Manifestations (5)  ·  Pain (5)

Interventions

Ticagrelor (4)  ·  cangrelor (4)  ·  Aspirin (3)  ·  Blood Specimen Collection (3)  ·  Heparin (3)  ·  2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine (2)  ·  Clopidogrel (2)  ·  Electrocardiography (2)  ·  Fibrinolytic Agents (2)  ·  Rivaroxaban (2)  ·  bivalirudin (2)  ·  dapagliflozin (2)  ·  Acetaminophen (1)  ·  Adrenergic beta-Antagonists (1)  ·  Angioplasty, Balloon (1)

Sponsors

Assiut University (5)  ·  Assistance Publique - Hôpitaux de Paris (3)  ·  Miracor Medical SA (3)  ·  Beijing Anzhen Hospital (2)  ·  Charite University, Berlin, Germany (2)  ·  CorFlow Therapeutics AG (2)  ·  Henry Ford Health System (2)  ·  Instituto Nacional de Cardiologia Ignacio Chavez (2)  ·  A.H. Tavenier (1)  ·  Abbott Medical Devices (1)  ·  Aristotle University Of Thessaloniki (1)  ·  Azienda Ospedaliera Sant'Anna e San Sebastiano (1)  ·  Beijing Friendship Hospital (1)  ·  Biosensors Europe SA (1)  ·  CeleCor Therapeutics (1)

Countries

China (11)  ·  United States (10)  ·  France (6)  ·  Netherlands (6)  ·  Germany (5)  ·  Italy (5)  ·  Denmark (4)  ·  Switzerland (4)  ·  United Kingdom (4)  ·  Belgium (3)  ·  Egypt (3)  ·  Hong Kong (3)  ·  Japan (3)  ·  Mexico (3)  ·  Spain (3)

Top investigators

Ulf Landmesser, MD (2)  ·  William W O'Neill, MD (2)  ·  Abdul Hakeem, MD (1)  ·  Adrian Banning, Prof. (1)  ·  Amr A. Youssef, Prof doctor (1)  ·  Arafa Gomaa, MD (1)  ·  Athanasios Zacharopoulos (1)  ·  Babar Basir, DO (1)  ·  Barbara Valente, MD (1)  ·  Binita Shah, MD (1)  ·  Cai De Jin, MD (1)  ·  Christos Arvanitidis (1)  ·  Christos Ouzounis (1)  ·  Damiana Pieragostino (1)  ·  David M Leistner, MD (1)

Results publications

PMID 11277825, PMID 15007110, PMID 16925605, PMID 17394957, PMID 18036459, PMID 18929686, PMID 19915221, PMID 19915222, PMID 19923168, PMID 21067804, PMID 21421184, PMID 22253393, PMID 22491499, PMID 23048167, PMID 23127386, PMID 23256914, PMID 23333655, PMID 23428006, PMID 23473369, PMID 23491524, PMID 23500251, PMID 23768460, PMID 23991622, PMID 24988003, PMID 25175921, PMID 25464218, PMID 25660931, PMID 26055262, PMID 26117471, PMID 26347918, PMID 27305194, PMID 27712739, PMID 27743953, PMID 27867288, PMID 30165437, PMID 30264159, PMID 30408229, PMID 31000179, PMID 31025538, PMID 31117810, PMID 31463362, PMID 31479722, PMID 32096064, PMID 32795098, PMID 32863246, PMID 32938773, PMID 33080003, PMID 33258102, PMID 33606413, PMID 34011835

NIH funding

2025 (2), 2016 (1), R01HL146206 (1)